课题基金 / 基金详情

High-fidelity epigenetic maintenance in somatic cells: CIZ1 assemblies as molecular shield

High-fidelity epigenetic maintenance in somatic cells: CIZ1 assemblies as molecular shield
体细胞中的高保真表观遗传维持:CIZ1 组件作为分​​子盾
批准号:
MR/V029088/1
负责人:
Dawn Coverley
金额:
$62.75万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2021
资助国家:
英国
项目状态:
未结题
起止时间:
2021 至 --

项目摘要

项目成果

Dawn Coverley的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cells in a developing embryo have the capability to become all of the different types of cell in the adult body. As they specialize they gradually turn off genes that are not required, until they only produce products that are essential to their function. One of the ways that their choice is restricted is by chemical modification of specific proteins (histones) that are closely associated with the genes to be shut down. Once established, these modifications must be stable, and also copied each time a cell divides so that daughter cells have the same repertoire as their parents, and therefore access the same genes as their parents. We are studying the processes that ensure histone modifications are faithfully maintained; the 'quality control' that stops a cell from drifting away from its path. Modifications are added by enzymes and removed by other enzymes, so the balance between these, and their relative ability to gain access to histones, governs whether specific histone modifications exist in a particular cell. This is fundamental to what the cell 'is' because it controls which genes it can express. Recently we showed that a protein called CIZ1 influences the stability of at least three different histone modifications, so that they are absent when CIZ1 is not able to form large assemblies inside the nucleus of cells. We think that these assemblies normally form a shield around selected genes and their histones, to protect them from the enzymes that remove the modifications. This project aims to understand whether interference with shield integrity can destabilize cells, setting them off down a path that could contribute to disease, and possibly aging. We specifically want to explore whether fragments of CIZ1 that are already associated with human diseases, can initiate cellular degeneration by destabilization of CIZ1 assemblies. We aim to use the information to consider how we might intervene (with drugs or diet) to prevent CIZ1 assembly destabilization.We also want to know whether interference with shield assembly ever happens during normal development, as a way of shifting the balance between 'on' and 'off' enzymes. This would be important to understand in the context of possible interventions. Finally, we plan to test how many different histone modifications are dependent on CIZ1, and under what conditions. So far, our analysis has been in cells taken from mouse embryos that are still developing, so it will be important to widen the picture to dividing and non-dividing cells taken from adult mice, and eventually humans.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1186/s12915-023-01671-6
发表时间: 2023-08-15
期刊: BMC BIOLOGY
影响因子: 5.4
作者: [Dobbs, Olivia G., Wilson, Rosemary H. C., Newling, Katherine, Ainscough, Justin F. -X., Coverley, Dawn]
通讯作者: Coverley, Dawn
DOI: 10.1101/2023.09.22.558821
发表时间: 2023-09
期刊: bioRxiv
影响因子: --
作者: [Gabrielle L. Turvey;Ernesto López de Alba;Emma R Stewart;Lewis Byrom;Heather Cook;Sajad Sofi;Ahmad Alalti;J. Ainscough;Andrew Mason;A. Antson;D. Coverley]
通讯作者: Gabrielle L. Turvey;Ernesto López de Alba;Emma R Stewart;Lewis Byrom;Heather Cook;Sajad Sofi;Ahmad Alalti;J. Ainscough;Andrew Mason;A. Antson;D. Coverley
Role of CIZ1 in maintenance of epigenetic landscape in primary differentiated cells
  • 批准号:
    MR/R008981/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $51.97万
  • 财政年份:
    2018
  • 负责人:
    Dawn Coverley
  • 依托单位:
国内基金
海外基金
NPM1表观重塑巨噬细胞代谢及修复表型在心肌缺血损伤中的调控作用
  • 批准号:
    82371825
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    占贞贞
  • 依托单位:
GLS1通过α-KG调控表观遗传修饰在实验性近视巩膜重塑中的作用机制
  • 批准号:
    82371092
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    柯碧莲
  • 依托单位:
小鼠肺腺鳞癌转分化类器官模型的建立及表观调控分子机制研究
MCM2、POLE3调控亲代组蛋白传递的分子机制和生物学功能